Global Helicobacter Pylori Diagnostics Market Analysis and Forecast 2024-2030
Summary
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
According to APO Research, The global Helicobacter Pylori Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Helicobacter Pylori Diagnostics include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Helicobacter Pylori Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Helicobacter Pylori Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Helicobacter Pylori Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Helicobacter Pylori Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Helicobacter Pylori Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Helicobacter Pylori Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Helicobacter Pylori Diagnostics segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Helicobacter Pylori Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Helicobacter Pylori Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Helicobacter Pylori Diagnostics revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
According to APO Research, The global Helicobacter Pylori Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Helicobacter Pylori Diagnostics include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Helicobacter Pylori Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Helicobacter Pylori Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Helicobacter Pylori Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Helicobacter Pylori Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Helicobacter Pylori Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Helicobacter Pylori Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Helicobacter Pylori Diagnostics segment by Company
- Sekisui Diagnostics
- F. Hoffmann-La Roche
- Medline Industries
- Meridian Bioscience
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Alpha Laboratories
- EKF Diagnostics
- Quidel
- Halyard Health
- Cardinal Health
- Beckman Coulter
- Agilent Technologies
- Coris BioConcept
- Invasive Techniques
- Non-invasive Techniques
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Helicobacter Pylori Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Helicobacter Pylori Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Helicobacter Pylori Diagnostics revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Helicobacter Pylori Diagnostics Market by Type
1.2.1 Global Helicobacter Pylori Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Invasive Techniques
1.2.3 Non-invasive Techniques
1.3 Helicobacter Pylori Diagnostics Market by Application
1.3.1 Global Helicobacter Pylori Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HELICOBACTER PYLORI DIAGNOSTICS MARKET DYNAMICS
2.1 Helicobacter Pylori Diagnostics Industry Trends
2.2 Helicobacter Pylori Diagnostics Industry Drivers
2.3 Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
2.4 Helicobacter Pylori Diagnostics Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Helicobacter Pylori Diagnostics Market Perspective (2019-2030)
3.2 Global Helicobacter Pylori Diagnostics Growth Trends by Region
3.2.1 Global Helicobacter Pylori Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Helicobacter Pylori Diagnostics Market Size by Region (2019-2024)
3.2.3 Global Helicobacter Pylori Diagnostics Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Helicobacter Pylori Diagnostics Revenue by Players
4.1.1 Global Helicobacter Pylori Diagnostics Revenue by Players (2019-2024)
4.1.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2019-2024)
4.1.3 Global Helicobacter Pylori Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Helicobacter Pylori Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Helicobacter Pylori Diagnostics Key Players Headquarters & Area Served
4.4 Global Helicobacter Pylori Diagnostics Players, Product Type & Application
4.5 Global Helicobacter Pylori Diagnostics Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Helicobacter Pylori Diagnostics Market CR5 and HHI
4.6.2 Global Top 5 and 10 Helicobacter Pylori Diagnostics Players Market Share by Revenue in 2023
4.6.3 2023 Helicobacter Pylori Diagnostics Tier 1, Tier 2, and Tier
5 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE BY TYPE
5.1 Global Helicobacter Pylori Diagnostics Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
5.3 Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2019-2030)
6 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE BY APPLICATION
6.1 Global Helicobacter Pylori Diagnostics Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
6.3 Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Sekisui Diagnostics
7.1.1 Sekisui Diagnostics Comapny Information
7.1.2 Sekisui Diagnostics Business Overview
7.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
7.1.5 Sekisui Diagnostics Recent Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Comapny Information
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
7.2.5 F. Hoffmann-La Roche Recent Developments
7.3 Medline Industries
7.3.1 Medline Industries Comapny Information
7.3.2 Medline Industries Business Overview
7.3.3 Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
7.3.5 Medline Industries Recent Developments
7.4 Meridian Bioscience
7.4.1 Meridian Bioscience Comapny Information
7.4.2 Meridian Bioscience Business Overview
7.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
7.4.5 Meridian Bioscience Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Comapny Information
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Comapny Information
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
7.6.5 Thermo Fisher Scientific Recent Developments
7.7 Alpha Laboratories
7.7.1 Alpha Laboratories Comapny Information
7.7.2 Alpha Laboratories Business Overview
7.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
7.7.5 Alpha Laboratories Recent Developments
7.8 EKF Diagnostics
7.8.1 EKF Diagnostics Comapny Information
7.8.2 EKF Diagnostics Business Overview
7.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
7.8.5 EKF Diagnostics Recent Developments
7.9 Quidel
7.9.1 Quidel Comapny Information
7.9.2 Quidel Business Overview
7.9.3 Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
7.9.5 Quidel Recent Developments
7.10 Halyard Health
7.10.1 Halyard Health Comapny Information
7.10.2 Halyard Health Business Overview
7.10.3 Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
7.10.5 Halyard Health Recent Developments
7.11 Cardinal Health
7.11.1 Cardinal Health Comapny Information
7.11.2 Cardinal Health Business Overview
7.11.3 Cardinal Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
7.11.5 Cardinal Health Recent Developments
7.12 Beckman Coulter
7.12.1 Beckman Coulter Comapny Information
7.12.2 Beckman Coulter Business Overview
7.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
7.12.5 Beckman Coulter Recent Developments
7.13 Agilent Technologies
7.13.1 Agilent Technologies Comapny Information
7.13.2 Agilent Technologies Business Overview
7.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
7.13.5 Agilent Technologies Recent Developments
7.14 Coris BioConcept
7.14.1 Coris BioConcept Comapny Information
7.14.2 Coris BioConcept Business Overview
7.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
7.14.5 Coris BioConcept Recent Developments
8 NORTH AMERICA
8.1 North America Helicobacter Pylori Diagnostics Revenue (2019-2030)
8.2 North America Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
8.2.1 North America Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
8.2.2 North America Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
8.3 North America Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
8.4 North America Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
8.4.1 North America Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
8.4.2 North America Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
8.5 North America Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
8.6 North America Helicobacter Pylori Diagnostics Revenue by Country
8.6.1 North America Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
8.6.3 North America Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Helicobacter Pylori Diagnostics Revenue (2019-2030)
9.2 Europe Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
9.2.1 Europe Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
9.2.2 Europe Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
9.3 Europe Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
9.4 Europe Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
9.4.1 Europe Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
9.4.2 Europe Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
9.5 Europe Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
9.6 Europe Helicobacter Pylori Diagnostics Revenue by Country
9.6.1 Europe Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
9.6.3 Europe Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Helicobacter Pylori Diagnostics Revenue (2019-2030)
10.2 China Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
10.2.1 China Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
10.2.2 China Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
10.3 China Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
10.4 China Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
10.4.1 China Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
10.4.2 China Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
10.5 China Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Helicobacter Pylori Diagnostics Revenue (2019-2030)
11.2 Asia Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
11.2.1 Asia Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
11.2.2 Asia Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
11.3 Asia Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
11.4 Asia Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
11.4.1 Asia Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
11.4.2 Asia Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
11.5 Asia Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
11.6 Asia Helicobacter Pylori Diagnostics Revenue by Country
11.6.1 Asia Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
11.6.3 Asia Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Helicobacter Pylori Diagnostics Revenue (2019-2030)
12.2 MEALA Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
12.2.1 MEALA Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
12.2.2 MEALA Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
12.3 MEALA Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
12.4 MEALA Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
12.4.1 MEALA Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
12.4.2 MEALA Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
12.5 MEALA Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
12.6 MEALA Helicobacter Pylori Diagnostics Revenue by Country
12.6.1 MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
12.6.3 MEALA Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Helicobacter Pylori Diagnostics Market by Type
1.2.1 Global Helicobacter Pylori Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Invasive Techniques
1.2.3 Non-invasive Techniques
1.3 Helicobacter Pylori Diagnostics Market by Application
1.3.1 Global Helicobacter Pylori Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HELICOBACTER PYLORI DIAGNOSTICS MARKET DYNAMICS
2.1 Helicobacter Pylori Diagnostics Industry Trends
2.2 Helicobacter Pylori Diagnostics Industry Drivers
2.3 Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
2.4 Helicobacter Pylori Diagnostics Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Helicobacter Pylori Diagnostics Market Perspective (2019-2030)
3.2 Global Helicobacter Pylori Diagnostics Growth Trends by Region
3.2.1 Global Helicobacter Pylori Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Helicobacter Pylori Diagnostics Market Size by Region (2019-2024)
3.2.3 Global Helicobacter Pylori Diagnostics Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Helicobacter Pylori Diagnostics Revenue by Players
4.1.1 Global Helicobacter Pylori Diagnostics Revenue by Players (2019-2024)
4.1.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2019-2024)
4.1.3 Global Helicobacter Pylori Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Helicobacter Pylori Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Helicobacter Pylori Diagnostics Key Players Headquarters & Area Served
4.4 Global Helicobacter Pylori Diagnostics Players, Product Type & Application
4.5 Global Helicobacter Pylori Diagnostics Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Helicobacter Pylori Diagnostics Market CR5 and HHI
4.6.2 Global Top 5 and 10 Helicobacter Pylori Diagnostics Players Market Share by Revenue in 2023
4.6.3 2023 Helicobacter Pylori Diagnostics Tier 1, Tier 2, and Tier
5 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE BY TYPE
5.1 Global Helicobacter Pylori Diagnostics Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
5.3 Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2019-2030)
6 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE BY APPLICATION
6.1 Global Helicobacter Pylori Diagnostics Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
6.3 Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Sekisui Diagnostics
7.1.1 Sekisui Diagnostics Comapny Information
7.1.2 Sekisui Diagnostics Business Overview
7.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
7.1.5 Sekisui Diagnostics Recent Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Comapny Information
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
7.2.5 F. Hoffmann-La Roche Recent Developments
7.3 Medline Industries
7.3.1 Medline Industries Comapny Information
7.3.2 Medline Industries Business Overview
7.3.3 Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
7.3.5 Medline Industries Recent Developments
7.4 Meridian Bioscience
7.4.1 Meridian Bioscience Comapny Information
7.4.2 Meridian Bioscience Business Overview
7.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
7.4.5 Meridian Bioscience Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Comapny Information
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Comapny Information
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
7.6.5 Thermo Fisher Scientific Recent Developments
7.7 Alpha Laboratories
7.7.1 Alpha Laboratories Comapny Information
7.7.2 Alpha Laboratories Business Overview
7.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
7.7.5 Alpha Laboratories Recent Developments
7.8 EKF Diagnostics
7.8.1 EKF Diagnostics Comapny Information
7.8.2 EKF Diagnostics Business Overview
7.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
7.8.5 EKF Diagnostics Recent Developments
7.9 Quidel
7.9.1 Quidel Comapny Information
7.9.2 Quidel Business Overview
7.9.3 Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
7.9.5 Quidel Recent Developments
7.10 Halyard Health
7.10.1 Halyard Health Comapny Information
7.10.2 Halyard Health Business Overview
7.10.3 Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
7.10.5 Halyard Health Recent Developments
7.11 Cardinal Health
7.11.1 Cardinal Health Comapny Information
7.11.2 Cardinal Health Business Overview
7.11.3 Cardinal Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
7.11.5 Cardinal Health Recent Developments
7.12 Beckman Coulter
7.12.1 Beckman Coulter Comapny Information
7.12.2 Beckman Coulter Business Overview
7.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
7.12.5 Beckman Coulter Recent Developments
7.13 Agilent Technologies
7.13.1 Agilent Technologies Comapny Information
7.13.2 Agilent Technologies Business Overview
7.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
7.13.5 Agilent Technologies Recent Developments
7.14 Coris BioConcept
7.14.1 Coris BioConcept Comapny Information
7.14.2 Coris BioConcept Business Overview
7.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
7.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
7.14.5 Coris BioConcept Recent Developments
8 NORTH AMERICA
8.1 North America Helicobacter Pylori Diagnostics Revenue (2019-2030)
8.2 North America Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
8.2.1 North America Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
8.2.2 North America Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
8.3 North America Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
8.4 North America Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
8.4.1 North America Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
8.4.2 North America Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
8.5 North America Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
8.6 North America Helicobacter Pylori Diagnostics Revenue by Country
8.6.1 North America Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
8.6.3 North America Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Helicobacter Pylori Diagnostics Revenue (2019-2030)
9.2 Europe Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
9.2.1 Europe Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
9.2.2 Europe Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
9.3 Europe Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
9.4 Europe Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
9.4.1 Europe Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
9.4.2 Europe Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
9.5 Europe Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
9.6 Europe Helicobacter Pylori Diagnostics Revenue by Country
9.6.1 Europe Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
9.6.3 Europe Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Helicobacter Pylori Diagnostics Revenue (2019-2030)
10.2 China Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
10.2.1 China Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
10.2.2 China Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
10.3 China Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
10.4 China Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
10.4.1 China Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
10.4.2 China Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
10.5 China Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Helicobacter Pylori Diagnostics Revenue (2019-2030)
11.2 Asia Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
11.2.1 Asia Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
11.2.2 Asia Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
11.3 Asia Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
11.4 Asia Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
11.4.1 Asia Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
11.4.2 Asia Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
11.5 Asia Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
11.6 Asia Helicobacter Pylori Diagnostics Revenue by Country
11.6.1 Asia Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
11.6.3 Asia Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Helicobacter Pylori Diagnostics Revenue (2019-2030)
12.2 MEALA Helicobacter Pylori Diagnostics Revenue by Type (2019-2030)
12.2.1 MEALA Helicobacter Pylori Diagnostics Revenue by Type (2019-2024)
12.2.2 MEALA Helicobacter Pylori Diagnostics Revenue by Type (2025-2030)
12.3 MEALA Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
12.4 MEALA Helicobacter Pylori Diagnostics Revenue by Application (2019-2030)
12.4.1 MEALA Helicobacter Pylori Diagnostics Revenue by Application (2019-2024)
12.4.2 MEALA Helicobacter Pylori Diagnostics Revenue by Application (2025-2030)
12.5 MEALA Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
12.6 MEALA Helicobacter Pylori Diagnostics Revenue by Country
12.6.1 MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019-2024)
12.6.3 MEALA Helicobacter Pylori Diagnostics Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Invasive Techniques Major Manufacturers
Table 2. Non-invasive Techniques Major Manufacturers
Table 3. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Hospitals and Clinics Major Manufacturers
Table 5. Diagnostic Laboratories Major Manufacturers
Table 6. Others Major Manufacturers
Table 7. Helicobacter Pylori Diagnostics Industry Trends
Table 8. Helicobacter Pylori Diagnostics Industry Drivers
Table 9. Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
Table 10. Helicobacter Pylori Diagnostics Industry Restraints
Table 11. Global Helicobacter Pylori Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Helicobacter Pylori Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Helicobacter Pylori Diagnostics Market Share by Region (2019-2024)
Table 14. Global Helicobacter Pylori Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Helicobacter Pylori Diagnostics Market Share by Region (2025-2030)
Table 16. Global Helicobacter Pylori Diagnostics Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2019-2024)
Table 18. Global Helicobacter Pylori Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Helicobacter Pylori Diagnostics Key Players Headquarters & Area Served
Table 20. Global Helicobacter Pylori Diagnostics Players, Product Type & Application
Table 21. Global Helicobacter Pylori Diagnostics Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Helicobacter Pylori Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Helicobacter Pylori Diagnostics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Helicobacter Pylori Diagnostics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Sekisui Diagnostics Company Information
Table 35. Sekisui Diagnostics Business Overview
Table 36. Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 38. Sekisui Diagnostics Recent Development
Table 39. F. Hoffmann-La Roche Company Information
Table 40. F. Hoffmann-La Roche Business Overview
Table 41. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
Table 43. F. Hoffmann-La Roche Recent Development
Table 44. Medline Industries Company Information
Table 45. Medline Industries Business Overview
Table 46. Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
Table 48. Medline Industries Recent Development
Table 49. Meridian Bioscience Company Information
Table 50. Meridian Bioscience Business Overview
Table 51. Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
Table 53. Meridian Bioscience Recent Development
Table 54. Bio-Rad Laboratories Company Information
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 58. Bio-Rad Laboratories Recent Development
Table 59. Thermo Fisher Scientific Company Information
Table 60. Thermo Fisher Scientific Business Overview
Table 61. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
Table 63. Thermo Fisher Scientific Recent Development
Table 64. Alpha Laboratories Company Information
Table 65. Alpha Laboratories Business Overview
Table 66. Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 68. Alpha Laboratories Recent Development
Table 69. EKF Diagnostics Company Information
Table 70. EKF Diagnostics Business Overview
Table 71. EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 73. EKF Diagnostics Recent Development
Table 74. Quidel Company Information
Table 75. Quidel Business Overview
Table 76. Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Quidel Helicobacter Pylori Diagnostics Product Portfolio
Table 78. Quidel Recent Development
Table 79. Halyard Health Company Information
Table 80. Halyard Health Business Overview
Table 81. Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
Table 83. Halyard Health Recent Development
Table 84. Cardinal Health Company Information
Table 85. Cardinal Health Business Overview
Table 86. Cardinal Health Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
Table 88. Cardinal Health Recent Development
Table 89. Beckman Coulter Company Information
Table 90. Beckman Coulter Business Overview
Table 91. Beckman Coulter Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
Table 93. Beckman Coulter Recent Development
Table 94. Agilent Technologies Company Information
Table 95. Agilent Technologies Business Overview
Table 96. Agilent Technologies Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
Table 98. Agilent Technologies Recent Development
Table 99. Coris BioConcept Company Information
Table 100. Coris BioConcept Business Overview
Table 101. Coris BioConcept Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
Table 103. Coris BioConcept Recent Development
Table 104. North America Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 105. North America Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 106. North America Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 107. North America Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 108. North America Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 109. Europe Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 110. Europe Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 111. Europe Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 112. Europe Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 113. Europe Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 114. China Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 115. China Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 116. Asia Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 117. Asia Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 118. Asia Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. Asia Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 120. Asia Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 121. MEALA Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 122. MEALA Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 123. MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 124. MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 125. MEALA Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 126. Research Programs/Design for This Report
Table 127. Authors List of This Report
Table 128. Secondary Sources
Table 129. Primary Sources
Table 1. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Invasive Techniques Major Manufacturers
Table 2. Non-invasive Techniques Major Manufacturers
Table 3. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Hospitals and Clinics Major Manufacturers
Table 5. Diagnostic Laboratories Major Manufacturers
Table 6. Others Major Manufacturers
Table 7. Helicobacter Pylori Diagnostics Industry Trends
Table 8. Helicobacter Pylori Diagnostics Industry Drivers
Table 9. Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
Table 10. Helicobacter Pylori Diagnostics Industry Restraints
Table 11. Global Helicobacter Pylori Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Helicobacter Pylori Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Helicobacter Pylori Diagnostics Market Share by Region (2019-2024)
Table 14. Global Helicobacter Pylori Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Helicobacter Pylori Diagnostics Market Share by Region (2025-2030)
Table 16. Global Helicobacter Pylori Diagnostics Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2019-2024)
Table 18. Global Helicobacter Pylori Diagnostics Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Helicobacter Pylori Diagnostics Key Players Headquarters & Area Served
Table 20. Global Helicobacter Pylori Diagnostics Players, Product Type & Application
Table 21. Global Helicobacter Pylori Diagnostics Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Helicobacter Pylori Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Helicobacter Pylori Diagnostics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Helicobacter Pylori Diagnostics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Sekisui Diagnostics Company Information
Table 35. Sekisui Diagnostics Business Overview
Table 36. Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 38. Sekisui Diagnostics Recent Development
Table 39. F. Hoffmann-La Roche Company Information
Table 40. F. Hoffmann-La Roche Business Overview
Table 41. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
Table 43. F. Hoffmann-La Roche Recent Development
Table 44. Medline Industries Company Information
Table 45. Medline Industries Business Overview
Table 46. Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
Table 48. Medline Industries Recent Development
Table 49. Meridian Bioscience Company Information
Table 50. Meridian Bioscience Business Overview
Table 51. Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
Table 53. Meridian Bioscience Recent Development
Table 54. Bio-Rad Laboratories Company Information
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 58. Bio-Rad Laboratories Recent Development
Table 59. Thermo Fisher Scientific Company Information
Table 60. Thermo Fisher Scientific Business Overview
Table 61. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
Table 63. Thermo Fisher Scientific Recent Development
Table 64. Alpha Laboratories Company Information
Table 65. Alpha Laboratories Business Overview
Table 66. Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 68. Alpha Laboratories Recent Development
Table 69. EKF Diagnostics Company Information
Table 70. EKF Diagnostics Business Overview
Table 71. EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 73. EKF Diagnostics Recent Development
Table 74. Quidel Company Information
Table 75. Quidel Business Overview
Table 76. Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Quidel Helicobacter Pylori Diagnostics Product Portfolio
Table 78. Quidel Recent Development
Table 79. Halyard Health Company Information
Table 80. Halyard Health Business Overview
Table 81. Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
Table 83. Halyard Health Recent Development
Table 84. Cardinal Health Company Information
Table 85. Cardinal Health Business Overview
Table 86. Cardinal Health Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
Table 88. Cardinal Health Recent Development
Table 89. Beckman Coulter Company Information
Table 90. Beckman Coulter Business Overview
Table 91. Beckman Coulter Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
Table 93. Beckman Coulter Recent Development
Table 94. Agilent Technologies Company Information
Table 95. Agilent Technologies Business Overview
Table 96. Agilent Technologies Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
Table 98. Agilent Technologies Recent Development
Table 99. Coris BioConcept Company Information
Table 100. Coris BioConcept Business Overview
Table 101. Coris BioConcept Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
Table 103. Coris BioConcept Recent Development
Table 104. North America Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 105. North America Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 106. North America Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 107. North America Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 108. North America Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 109. Europe Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 110. Europe Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 111. Europe Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 112. Europe Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 113. Europe Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 114. China Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 115. China Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 116. Asia Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 117. Asia Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 118. Asia Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. Asia Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 120. Asia Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 121. MEALA Helicobacter Pylori Diagnostics Revenue by Type (2019-2024) & (US$ Million)
Table 122. MEALA Helicobacter Pylori Diagnostics Revenue by Application (2019-2024) & (US$ Million)
Table 123. MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 124. MEALA Helicobacter Pylori Diagnostics Revenue by Country (2019-2024) & (US$ Million)
Table 125. MEALA Helicobacter Pylori Diagnostics Revenue by Country (2025-2030) & (US$ Million)
Table 126. Research Programs/Design for This Report
Table 127. Authors List of This Report
Table 128. Secondary Sources
Table 129. Primary Sources
LIST OF FIGURES
Figure 1. Helicobacter Pylori Diagnostics Product Picture
Figure 2. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Helicobacter Pylori Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Invasive Techniques Picture
Figure 5. Non-invasive Techniques Picture
Figure 6. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Helicobacter Pylori Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 8. Hospitals and Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Helicobacter Pylori Diagnostics Market Size (US$ Million) & (2019-2030)
Figure 12. Global Helicobacter Pylori Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Helicobacter Pylori Diagnostics Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Helicobacter Pylori Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Helicobacter Pylori Diagnostics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Helicobacter Pylori Diagnostics Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2019-2030)
Figure 19. Global Helicobacter Pylori Diagnostics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019-2030)
Figure 22. North America Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 25. North America Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 27. North America Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 28. United States Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 33. Europe Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 35. Europe Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 36. Germany Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 45. China Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 47. Asia Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 50. Asia Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 52. Asia Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 53. Japan Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 62. MEALA Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 64. MEALA Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 65. Mexico Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
Figure 1. Helicobacter Pylori Diagnostics Product Picture
Figure 2. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Helicobacter Pylori Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Invasive Techniques Picture
Figure 5. Non-invasive Techniques Picture
Figure 6. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Helicobacter Pylori Diagnostics Market Size Share 2019 VS 2023 VS 2030
Figure 8. Hospitals and Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Helicobacter Pylori Diagnostics Market Size (US$ Million) & (2019-2030)
Figure 12. Global Helicobacter Pylori Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Helicobacter Pylori Diagnostics Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Helicobacter Pylori Diagnostics Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Helicobacter Pylori Diagnostics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Helicobacter Pylori Diagnostics Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2019-2030)
Figure 19. Global Helicobacter Pylori Diagnostics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2019-2030)
Figure 22. North America Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 25. North America Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 27. North America Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 28. United States Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 33. Europe Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 35. Europe Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 36. Germany Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 45. China Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 47. Asia Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 50. Asia Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 52. Asia Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 53. Japan Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Helicobacter Pylori Diagnostics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Helicobacter Pylori Diagnostics Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Helicobacter Pylori Diagnostics Revenue Share by Type (2019-2030)
Figure 62. MEALA Helicobacter Pylori Diagnostics Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Helicobacter Pylori Diagnostics Revenue Share by Application (2019-2030)
Figure 64. MEALA Helicobacter Pylori Diagnostics Revenue Share by Country (2019-2030)
Figure 65. Mexico Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
